Researchers looked at the change in hormones and amino acid levels following gastric bypass surgery….
Read More »Diabetes In Control
Fish Oil May Reduce Risk of Type 2 Diabetes
Harvard School of Public Health researchers have published a study focused on the effects of fish oil on circulating adiponectin….
Read More »Acupuncture Improves Diabetes Related Gastroparesis
In a small study, diabetes patients with gastroparesis experienced significant relief of nausea when using needleless acupuncture….
Read More »Prepared Meals Can Provide Greater Weight Loss
Following a portion-controlled, pre-packaged meal plan may help shed extra weight and keep it off when compared to traditional diets….
Read More »Metformin Fails to Improve Survival Rates in Breast Cancer Patients
In a select sample of breast cancer patients, the possible anti-cancer effects of metformin do not significantly increase survival rates….
Read More »Editor’s Note, DCMS #138
This week in our Homerun Slides we get back to working with medications to focus on the core defects of diabetes and how selecting the right combinations can make a difference in the synergy and results, while our Disaster Averted looks at what happens when there are transcribing and order …
Read More »Diabetic Emergencies, Diagnosis and Clinical Management: Hyperosmolar Non-ketotic Hyperglycemia, Part 4
Konstantinos Makrilakis, MD, PhD Nikolaos Katsilambros, MD, PhD. Avoidance of complications Hypoglycemia and hypokalemia are the two most common complications of treatment of hyperglycemic crises with insulin. They have both been reduced significantly, however, with the administration of low-dose insulin and careful monitoring and replacement of serum potassium. 27,28 Frequent …
Read More »Core Defects of Type 2 Diabetes, Part 3 of 4
With this week’s Homerun Slides, we pick up again on our Core Defects of Type 2 Diabetes series with Part 3. This set delves into the Targeting Mechanisms for a Comprehensive Approach, Complementary Mechanisms of Action, with a focus on sitagliptin…
Read More »Letter from the Editor #678
We are at a point with oral medications for diabetes where there are new drug approvals in recently approved classes, new drug classes where the first in class is approved, as well as late trial research moving quickly for drugs in yet unapproved classes. First it was the DPP-4 inhibitors with …
Read More »Diabetes among US Adults Grew by 45% over 20 Years
Diabetes among US Adults Grew by 45% over 20 Years See this week’s Item #2.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.